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ctivation of mammalian Notch receptor by its ligands
induces TNF
 
 
 
-converting enzyme–dependent ecto-
domain shedding, followed by intramembrane proteo-
lysis due to presenilin (PS)-dependent 
 
 
 
-secretase activity.
Here, we demonstrate that a new modiﬁcation, a mono-
ubiquitination, as well as clathrin-dependent endocytosis,
is required for 
 
 
 
-secretase processing of a constitutively active
Notch derivative, 
 
 
 
E, which mimics the TNF
 
 
 
-converting
A
 
enzyme–processing product. PS interacts with this modiﬁed
form of 
 
 
 
E, 
 
 
 
E
 
u
 
. We identiﬁed the lysine residue targeted
by the monoubiquitination event and conﬁrmed its impor-
tance for activation of Notch receptor by its ligand, Delta-
like 1. We propose a new model where monoubiquitin-
ation and endocytosis of Notch are a prerequisite for its
PS-dependent cleavage, and discuss its relevance for other
 
 
 
-secretase substrates.
 
Introduction
 
During the development of both invertebrates and verte-
brates, the Notch pathway ensures correct specification of
multiple cell types. The Notch gene encodes a large single-
pass transmembrane (TM) receptor, matured in the secretory
pathway by a convertase of the furin family, and presented at
the cell surface as a heterodimeric molecule (Logeat et al.,
1998). Binding of Notch ligands (Delta or Jagged in mam-
mals) causes a proteolytic cleavage in the extracellular domain
of Notch due to a protease of the ADAM family, TNF
 
 
 
-
converting enzyme (TACE; Brou et al., 2000; Mumm et al.,
2000). The remaining membrane-tethered Notch is then
cleaved within its TM domain, leading to the release of the
intracellular domain of Notch1 (ICv; (Kopan et al., 1994,
1996; Jarriault et al., 1995). The ICv domain translocates into
the nucleus, where it participates in transcriptional activation
of target genes together with CSL and Mastermind (Kitagawa
et al., 2001). TM cleavage of Notch is due to a 
 
 
 
-secretase-
like activity, analogous to the one that cleaves amyloid 
 
 
 
 pre-
cursor protein (APP; Fortini, 2002). Recent data suggest that
 
 
 
-secretase cleavage is mediated by a large protein complex
containing an aspartyl–protease activity. This high molecular
weight complex may consist of one of the two presenilins
(PSs) carrying the enzymatic activity, and of other regulatory
proteins, namely Nicastrin/APH-2, APH-1, and Pen-2 (Fortini,
2002). The majority of the PS pool is located within the ER
and the Golgi apparatus (De Strooper et al., 1997; Zhang et
al., 1998; Annaert et al., 1999), but more recent evidence
suggests a distribution at the cell surface and in endocytic
compartments (Georgakopoulos et al., 1999; Ray et al., 1999;
Lah and Levey, 2000; Cupers et al., 2001; Kaether et al.,
2002). Analyses of Nicastrin suggest that the mature, PS- and
Nicastrin-containing 
 
 
 
-secretase complex is found in com-
partments distal to the ER (Yang et al., 2002) and in lysosomal
membranes (Pasternak et al., 2003). Moreover, the 
 
 
 
-secretase
activity itself has been suggested to be located in a compart-
ment distal to the ER–Golgi (Cataldo et al., 2000; Cupers et
al., 2001; Grbovic et al., 2003).
Endocytosis has been shown to play a role in Notch sig-
naling in 
 
Drosophila
 
 and in 
 
Caenorhabditis elegans
 
, although
its direct role in 
 
 
 
-secretase cleavage of the receptor has not
been proven yet. 
 
Shibire
 
, the fly dynamin homologue, is
necessary in ligand-expressing cells as well as in signal-receiving
cells for proper Notch signaling (Seugnet et al., 1997).
Dynamin is involved in endocytosis through its role in the
formation and pinching off of clathrin-coated vesicles from
the plasma membrane. Its involvement in the Notch path-
way suggests the activity of both ligand and receptor is regu-
lated by endocytosis. In the emitting cell, it has been shown
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that Delta can trigger transendocytosis of the Notch extracellu-
lar domain after TACE cleavage (Parks et al., 2000). However,
in the receiving cell, endocytosis of the receptor itself and its
function in the signaling process has been poorly documented.
In 
 
C. elegans
 
, endocytosis-mediated down-regulation of the
lin12/Notch pathway has been described (Shaye and Green-
wald, 2002), but it could correspond to a constitutive internal-
ization allowing recycling or degradation of the receptor. In
 
Drosophila
 
, it has been proposed that 
 
 
 
-secretase proteolysis
of Notch occurs within the apical membrane or in an associated
endosomal compartment (Lopez-Schier and St. Johnston, 2002).
Based on these data, we hypothesized that after ligand binding,
some trafficking of Notch and/or of the PS-containing complex
is required for the 
 
 
 
-secretase cleavage. Here, we demonstrate
that PSs interact with a monoubiquitinated form of activated
Notch. This modification, as well as an endocytosis step, pre-
cedes and is necessary for 
 
 
 
-secretase cleavage of Notch.
 
Results
 
Endocytosis is required before 
 
 
 
-secretase cleavage 
of Notch
 
To elucidate the events occurring after TACE proteolysis,
we took advantage of the Notch 
 
 
 
E expression vector (Ko-
pan et al., 1996). 
 
 
 
E encodes 
 
 
 
E
 
TM
 
, a truncated form of the
Notch1 receptor (see Fig. 2 B) lacking most of its extracellu-
lar domain, but containing the signal peptide fused to the 21
amino acids NH
 
2
 
-terminal to the TM domain, the TM do-
main, and the intracellular domain. 
 
 
 
E
 
TM
 
 is very analogous
to the natural TACE-processing product of Notch1 that is
generated after ligand binding (Brou et al., 2000). It is con-
stitutively cleaved by 
 
 
 
-secretase (De Strooper et al., 1999),
thus releasing the transcriptionally active nuclear form of
Notch, ICv (Fig. 1 A, A1). We mainly used COOH-termi-
nally truncated forms of the constructs, where the last 355
amino acids of the Notch receptor have been replaced by
6-myc epitopes (Kopan et al., 1996). This truncation deletes
the PEST domain, and the derived ICv is more stable than
its full-length counterpart (Gupta-Rossi et al., 2001). To de-
termine whether an endocytosis step was involved in 
 
 
 
E
 
TM
 
processing, we inhibited endocytosis by transfecting a GFP-
conjugated Eps15 dominant-negative mutant (Eps15DN)
deleted of its EH domains (Benmerah et al., 1999). As a
control, we monitored endocytosis of the transferrin recep-
tor by using a fluorescent dye–labeled transferrin (CY3-Tf).
In the cells overexpressing Eps15DN (Fig. 1 A, B1), endocy-
tosis of the transferrin receptor (Fig. 1 A, B2) was inhibited,
as no intracellular fluorescence could be detected (Fig. 1
Figure 1. Endocytosis is required for  -secretase 
cleavage of Notch  E. (A) Endocytosis is required 
for nuclear localization of  E derivatives. HeLa cells 
were transiently transfected with  E (A and C) and/or 
a dominant-negative form of GFP-fused Eps15 (B and 
C, EPS15DN). In A and B, living cells were first incu-
bated with CY3-Tf for 1 h at 37 C. Eps15DN was visu-
alized directly by the fluorescence emitted by GFP 
(B1, B3, C1, and C3), whereas  E was detected using 
an anti-myc antibody (Alexa 488
® labeled in green: 
A1 and A3; CY3 labeled in red: C2 and C3). CY3-Tf 
reveals the internalization of transferrin receptor (in red: 
A2, A3, B2, and B3). Panels numbered 3 are merges 
of the corresponding panels 1 and 2. (B)  -Secretase 
processing of  E is inhibited by overexpression of 
dominant-negative forms of dynamin2 (dynK44A) 
and Eps15 (Eps15DN). 293T cells were transfected 
with plasmids encoding  E (lanes 1–4),  E along 
with dynK44A (lanes 5 and 6) or Eps15DN (lanes 7 
and 8), or ICv (lane 9). Cells were pulse labeled with 
[
35S]methionine and chased for 1 h. 50  M MW167 
(lanes 3 and 4) was added as indicated in the Materials 
and methods. Anti-myc immunoprecipitated cell 
extracts were analyzed by SDS-PAGE followed by 
autoradiography.  ETM indicates the  E membrane-
anchored form, asterisks mark 95- and 150-kD migrat-
ing products corresponding respectively to dynK44A 
(lanes 5 and 6) and Eps15DN (lanes 7 and 8). The ratio 
between ICv and  ETM was quantified in this represen-
tative experiment using phosphorimager analysis to 
38, 9, and 20%, corresponding respectively to lanes 
2, 6, and 8. The open arrowhead shows a slower 
migrating band stabilized in the presence of MW167 
(lanes 3 and 4). 
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A, B3; cell surface receptor labeling expected here being
washed out by Triton permeabilization). Overexpression of
Eps15DN in 
 
 
 
E-transfected cells led to nuclear exclusion of
Notch products (Fig. 1 A, compare A1 with C2). When an
expression vector encoding myc-tagged ICv was cotrans-
fected with Eps15DN, the anti-myc labeling was exclusively
nuclear, showing that ICv nuclear transport was not affected
(unpublished data). We obtained the same results when re-
placing Eps15DN with a dominant-negative form of dy-
namin 2 (dynK44A; McNiven et al., 2000; unpublished
data). These data suggest that inhibition of endocytosis pre-
vents 
 
 
 
-secretase cleavage. To verify this hypothesis, we per-
formed a pulse-chase analysis of 
 
 
 
E-transfected cells in the
presence or absence of dynK44A or Eps15DN (Fig. 1 B) in
HEK 293T cells. 
 
 
 
E
 
TM
 
-derived ICv was visualized after a
1-h chase (Fig. 1 B, compare lane 2 with lane 9), but not af-
ter treatment with MW167 (Wolfe et al., 1998), a specific
inhibitor of 
 
 
 
-secretase activity (Fig. 1 B, lanes 3 and 4).
DynK44A coexpression inhibited ICv production; so did
Eps15DN to a lesser extent (compare the ratio between ICv
and 
 
 
 
E
 
TM
 
 in lanes 2, 6, and 8, quantified to 38, 9, and 20%,
respectively). The 95- and 150-kD migrating products
detected respectively in lanes 5 and 6 and in lanes 7 and 8
(Fig. 1 B, asterisks) probably correspond to dynK44A and
Eps15DN, suggesting that they directly or indirectly associ-
ate with Notch. We conclude from these experiments that
an endocytosis step is necessary before 
 
 
 
-secretase cleavage.
 
PSs interact with a modified form of 
 
 
 
E
 
A slower migrating product (open arrowhead) that was sta-
bilized in the presence of the 
 
 
 
-secretase inhibitor could be
visualized in Fig. 1 B (lanes 3 and 4). We assumed that it
might represent a specific modification that targets 
 
 
 
E
 
TM
 
Figure 2.
 
PSs interact with a monoubiquitinated form of 
 
 
 
E, 
 
 
 
E
 
u
 
.
 
 
(A) Analysis of PS1–Notch interaction. 293T cells were transfected 
with 
 
 
 
E (lanes 1–4), 
 
 
 
E
 
 
 
CT (lanes 5 and 6), and PS1 (lanes 3, 4, 
and 6) expression vectors for 24 h, then treated with MW167 for 3 h 
when indicated. Extracts or PS1 immunoprecipitates (IP) were 
analyzed by SDS-PAGE (4–12%, lanes 1–4; 5%, lanes 5 and 6) and 
immunoblotted with antibodies against myc, Notch, or the loop 
domain of PS1 (recognizing PS1
 
FL
 
 and PS1
 
CTF
 
). 
 
 
 
E
 
TM
 
 and 
 
 
 
E
 
 
 
CT
 
TM
 
 
represent the membrane-anchored forms encoded by the expression 
vectors; 
 
 
 
E
 
u
 
 and 
 
 
 
E
 
 
 
CT
 
U
 
 are the novel modified forms revealed by 
this assay. (B) Constructs used in this paper. Top, Notch derivatives: 
FL, 
 
 
 
E, and ICv forms, and the epitopes recognized by the antibodies 
used are represented. Note that 
 
pepex
 
 and V1744 respectively 
recognize the membrane-anchored 
 
 
 
E and the 
 
 
 
-secretase cleavage 
product ICv, whereas anti-myc and anti-Notch (not depicted) anti-
bodies detect all the derivatives. FL
 
TM
 
 represents the TM subunit of 
Notch heterodimer resulting from furin cleavage. Bottom, PS2 and 
its derivative, 
 
 
 
C4. 
 
 
 
C4 encodes the NH
 
2
 
-terminal 168 aa of PS2, 
containing its two first TM domains. (C) 
 
 
 
C4 specifically interacts 
with 
 
 
 
E-derived forms. 293T cells were transfected with either Notch 
FL (lanes 1 and 2), 
 
 
 
E (lanes 3 and 4), or ICv (lanes 5 and 6), along 
with 
 
 
 
C4 (even-numbered lanes). Total cell extracts (middle and 
bottom) and their immunoprecipitates obtained with anti-PS2 anti-
body (top) were analyzed by Western blotting using anti-myc (top 
and middle) or V1744 (bottom). (D) 
 
 
 
E
 
u
 
 results from monoubiquiti-
nation of 
 
 
 
E. 293T cells were transiently transfected with 
 
 
 
E, along 
with 
 
 
 
C4 and either WT ubiquitin (HA-tagged, lanes 1 and 2; VSV-
tagged, lanes 4 and 4
 
 
 
) or VSV-tagged UbKO (lanes 5 and 5
 
 
 
). In the 
top panel, cell extracts were immunoprecipitated with anti-PS2 
(lanes 1, 4
 
 
 
, and 5
 
 
 
), anti-HA (lanes 2 and 3), or anti-VSV (lanes 4 
and 5) before SDS-PAGE analysis. In the bottom panel, 2% of total 
protein lysates used for IP were loaded. Extracts from WT
 
VSV
 
 or KO
 
VSV
 
 
Ub-transfected cells (bottom, lanes 4 and 5, respectively) were 
divided into two halves for IP with either VSV (lanes 4 and 5) or PS2 
(lanes 4
 
 
 
 and 5
 
 
 
). Immunoblots were performed using anti-myc 
antibody. Asterisks indicate the 
 
 
 
E
u form in whole-cell extracts. 
(E) Dimerization of  E molecules. 293T cells were transfected with 
myc-tagged  E and/or an untagged, COOH-terminally truncated 
 E,  ER5, as indicated. The corresponding cell extracts were immuno-
blotted with anti-Notch antibody directly (lanes 1–3) or after anti-myc 
immunoprecipitation (lanes 4–6). The products derived from each 
construct are indicated:  E
u,  ETM, and ICv; and  ER5
u,  ER5TM, 
and ICvR5. White lines indicate that intervening lanes have been 
spliced out.76 The Journal of Cell Biology | Volume 166, Number 1, 2004
before  -secretase cleavage. As  -secretase is performed by a
complex containing PS, PS (1 or 2) should coimmunopre-
cipitate with the substrate of the enzyme. PS1 indeed inter-
acted with  ETM when both proteins were overexpressed in
HEK 293T cells (Fig. 2 A, lanes 3 and 4). The interaction
between endogenous PS1 and  ETM could also be detected
on a longer exposure (Fig. 2 A, lanes 1 and 2). Furthermore,
PS1 coimmunoprecipitation enabled us to reveal a novel
form,  E
u, either when PS1 was overexpressed (Fig. 2 A,
lanes 3 and 4) or when  -secretase activity was blocked by
MW167 treatment (Fig. 2 A, lane 2). Based on its apparent
molecular weight, it could correspond to the labile form vi-
sualized in Fig. 1 B, lanes 3 and 4. To verify that COOH-
terminal truncated forms of  E behave like their non-
truncated counterparts, we coimmunoprecipitated PS1 with
 E CT and could detect  E CTTM, as well as an upper-
migrating band,  E CT
U (Fig. 2 A, lanes 5 and 6). Then,
we tested whether the NH2-terminal part of PS1 or PS2
could account for Notch interaction, as previously described
for APP–PS interaction (Pradier et al., 1999). Indeed, im-
munoprecipitating  C4, which only contains the NH2-ter-
minal part of PS2 (Fig. 2 B), revealed  ETM and resulted in
enrichment of the  E
u form (Fig. 2 C, lane 4; compare top
and middle panels).  C4 did not coimmunoprecipitate with
the  ETM-derived (Fig. 2 C, lanes 3 and 4) or overexpressed
ICv (Fig. 2 C, lanes 5 and 6). ICv is revealed by direct im-
munoblotting with the V1744 antibody (Fig. 2 C bottom,
and see Fig. 2 B). Cotransfection of full-length Notch re-
vealed that the furin-cleaved membrane-anchored fragment
(Fig. 2 B, FLTM) was not able to bind  C4 either (Fig. 2 C,
lanes 1 and 2). The same results were observed with a PS1-
derived  C4 construct (unpublished data). As both PS and
 C4 bind membrane-associated  ETM-derived forms, we
used  C4 coimmunoprecipitation as a tool to select for
 -secretase substrates, this form being less toxic than the
full-length PS.
Monoubiquitination accounts for the  E
u form
As the  E
u form probably derives from  ETM and could rep-
resent an intermediate species necessary for either association
with or cleavage by the  -secretase, we decided to character-
ize the nature of this modification. Treatment with phos-
phatases or deglycosylases did not affect the  E
u band
(unpublished data), and the apparent molecular weight dif-
ference of 8 kD between  ETM and  E
u suggested that
this modification could be due to a monoubiquitination
event. Therefore, we cotransfected the cells with HA-tagged
ubiquitin together with  E and  C4. Immunoprecipitation
with the anti-HA antibody, followed by anti-myc immuno-
blotting, specifically revealed the same migration products as
those detected after anti-PS2 pull-down (Fig. 2 D, lanes
1–3), suggesting that  E
u contains an HA-ubiquitin moiety.
We also used a ubiquitin molecule (UbKO) mutated on all
its lysine residues and only able to form the first isopeptide
bond between its last glycine (G76) and a lysine residue on
the target protein (Wu et al., 2003). As shown in Fig. 2 D
(lanes 4, 4 , 5, and 5 ), immunoprecipitating ubiquitin or
 C4 followed by anti-myc immunoblotting revealed the
same migrating products, whether ubiquitin wild type (WT)
or KO were used. The fact that  ETM was specifically coim-
munoprecipitated with anti-ubiquitin as well as anti-PS2 an-
tibodies in the presence of  C4 can be explained by the for-
mation of dimeric molecules. Dimerization of  E molecules
was studied by cotransfecting  E along with a COOH-ter-
minally truncated  E devoid of the myc epitopes (Fig. 2 E,
 ER5). Immunoprecipitation with anti-myc antibody fol-
lowed by anti-Notch immunoblotting revealed  ETM and
 E
u, as well as  ER5TM and  ER5
u, showing that these pro-
teins were associated (Fig. 2 E, lane 6). From these ex-
periments, we propose that  E
u is derived from  ETM by
conjugation of a single ubiquitin moiety. This result was
confirmed by anti-ubiquitin immunoblotting of  C4 coim-
munoprecipitates (Fig. 3 C).
Monoubiquitination takes place on a juxtamembrane 
lysine residue and is necessary for  -secretase cleavage 
of ligand-activated Notch
Next, we tried to localize the lysine residue(s) targeted by
this ubiquitination event. In one of our previous reports, we
had used the  E-GAL-VP16 chimera ending at aa 1809 as a
substrate for  -secretase (Brou et al., 2000). It has also been
shown that inserting a GAL-VP16 moiety 9 amino acids
COOH-terminal to the  -secretase cleavage site (at aa 1753)
of mammalian Notch still allows  -secretase cleavage (as
measured by monitoring GAL-VP16 transcriptional activity;
Taniguchi et al., 2002). Therefore, the Notch fragment im-
mediately adjacent to the membrane probably contains any
amino acid whose modification is required for  -secretase
cleavage. Comparison of Notch sequences derived from var-
ious species (Fig. 3 A) shows a good conservation of the jux-
tamembrane lysine residue. Therefore, we mutated lysine
1749 of murine Notch1 to arginine (K1749R). We also
used the LLFF construct, a  E form mutated in the  -secre-
tase cleavage site (located after aa G1743; Schroeter et al.,
1998). First, we analyzed the localization of these mutants
when overexpressed in HeLa cells. In contrast to their WT
counterpart, none of the mutants presented a nuclear stain-
ing (Fig. 3 B), suggesting that ICv production was impaired.
The intracellular labeling may correspond to molecules traf-
ficking to the membrane or, inversely, in the process of en-
docytosis. Immunofluorescence experiments showed that
routing to the plasma membrane of these mutants was not
affected (see Fig. 5). The substitution of lysine 1749 by argi-
nine affected neither the localization nor the stability of the
corresponding ICv, as confirmed by immunofluorescence
and pulse-chase analysis (unpublished data). Therefore,
these mutations near the TM domain do not interfere with
correct addressing or stability of the proteins, but may pre-
vent   -secretase cleavage. Then, we determined whether
monoubiquitination, as well as  -secretase cleavage, was af-
fected in these mutants.  E
u was detected by coimmunopre-
cipitation with  C4 followed by immunoblotting with an
antibody recognizing ubiquitin moieties (Fig. 3 C top, lanes
1–3). Interestingly,  E
u was only revealed when using WT
or LLFF  E constructs, in contrast to K1749R, whereas
 ETM was coprecipitated with  C4 in all cases (Fig. 3 C
bottom, lanes 1–3; detected by reblotting with an anti-
Notch antibody). On the other hand, we tested the cell ex-Monoubiquitination and endocytosis of Notch | Gupta-Rossi et al. 77
tracts in parallel for the presence of  -secretase cleavage
products with V1744 antibody (Fig. 3 C top, lanes 4–8) and
for the total amount of Notch-derived products with anti-
myc antibody (Fig. 3 C bottom, same lanes). ICv was indeed
detected in extracts transfected with  E or ICv expression
vectors (Fig. 3 C, lanes 4 and 8), but was not produced
when cells were treated with MW167 (Fig. 3 C, lane 5) or
when the LLFF construct was used (Fig. 3 C, lane 7). When
using the K1749R mutant (Fig. 3 C, lane 6), ICv could still
be detected, but to a much lower extent than its WT coun-
terpart; this result being strengthened by the lower amount
of total Notch products in Fig. 3 C, lane 4 vs. lane 6. Thus,
the LLFF mutant can still be monoubiquitinated but not
 -secretase processed, whereas both events are strongly in-
hibited in the K1749R mutant.
To confirm our results in the context of the activation
of full-length Notch receptor, we transiently transfected
HeLa or HEK 293T cells with WT full-length Notch re-
ceptor (Notch FL) or its lysine 1749 mutant (FLK1749R)
and incubated them with the preclustered extracellular do-
main of the Notch ligand, Delta-like 1 (Dl-Fc; Hicks et al.,
2002). In comparison with Notch FL, FLK1749R-trans-
fected cells exhibited decreased ICv production after ligand
binding, as detected by immunoblotting (Fig. 4 A) and im-
munofluorescence (Fig. 4 B). FL or FLK1749R addressing
was not affected by this mutation (Fig. 4 B). The residual
ICv production detected in the K1749R mutants (FL and
 E) may be due to an overexpression effect and/or to the
use of secondary ubiquitination sites. These data sug-
gest that ubiquitination occurs before and is required for
 -secretase cleavage and that lysine 1749 is crucial for this
event.
Furthermore, as shown for  E, when cells were cotrans-
fected with Notch FL along with the Eps15DN expression
vectors, nuclear staining was no longer visible after activa-
tion in cells overexpressing Eps15DN (unpublished data).
This result confirms that ligand-activated Notch is endocy-
tosed before  -secretase cleavage.
Figure 3. Lysine 1749 monoubiquitination precedes  -secretase cleavage 
of  E. (A) Sequence alignment of the juxtamembrane region of various 
Notch receptors, beginning at the first residue of  E (not including the signal 
peptide). aa 1704–1753 of murine Notch l (first line) were compared with 
homologous and orthologous sequences (m: mouse, h: human, c: chicken, 
x: Xenopus, d: Drosophila). The TM region is boxed in gray and arrows 
mark the TACE and  -secretase cleavage sites. The double-headed arrow 
spans the immunopeptide sequence used to generate the pepex antibody 
(see Materials and methods). Sequence changes in K1749R and LLFF are 
underlined and italicized. Note that except Notch 4, all Notch sequences 
contain a conserved juxtamembrane lysine residue (aa 1749 of mNotch1, 
arrow in bold). (B) Subcellular localization of mutant forms of  E. HeLa 
cells were transiently transfected by  E (panel 1), LLFF (panel 2), or K1749R (panel 3) expression vectors. Cells were fixed, Triton-permeabilized, 
and stained for fluorescence microscopy using the anti-myc antibody revealed by Alexa 488
®–coupled secondary antibody. (C) Monoubiquitination 
of K1749 is required for  -secretase cleavage. 293T cells were transfected with  C4 (lanes 1–3), various  E forms (WT: lanes 1, 4, and 5; LLFF: 
lanes 2 and 7; K1749R: lanes 3 and 6), or ICv (lane 8). In lanes 1–3, cell extracts were subjected to immunoprecipitation with anti-PS2 antibody, 
analyzed by immunoblotting with anti-ubiquitin antibody (top), and reprobed with anti-Notch antibody (bottom). In lanes 4–8, cell extracts 
were directly blotted with V1744 (top) or anti-myc (bottom) antibodies. White lines indicate that intervening lanes have been spliced out.78 The Journal of Cell Biology | Volume 166, Number 1, 2004
Monoubiquitination of Notch triggers its endocytosis-
dependent  -secretase cleavage
If monoubiquitination is required for Notch to reach the
compartment where the  -secretase is active, the LLFF mu-
tant should be blocked in the subcellular location where
 -secretase cleavage takes place, whereas the K1749R mu-
tant should remain more upstream in the endocytic pathway
or at the plasma membrane, as the result of a lack of mono-
ubiquitination. To confirm this hypothesis, we performed
immunostaining on living cells using an antibody (pepex) di-
rected against aa 1705–1722 of Notch1, i.e., the extracellu-
lar, NH2-terminal part of  E (Fig. 2 B and Fig. 3 A). Thus,
we could visualize only the  E molecules that have reached
the plasma membrane and could thus bind the antibody
without interference with the intracellular molecules accu-
mulating in the ER or Golgi. We monitored, in parallel, en-
Figure 4. Lysine 1749 is critical for Notch signaling. (A) 293T cells were transfected 
with either ICv (lane 1), Notch FL (lanes 2 and 3), or FLK1749R (lanes 4 and 5). 
Notch FL activation was performed by overnight incubation with either control 
conditioned media (indicated as “ ” in lanes 2 and 4) or clustered Dl-Fc–
containing media ( , lanes 3 and 5). Total cell extracts were analyzed by V1744 
Western blotting (top) and were reprobed with anti-myc antibody (bottom). 
Full-length Notch precursor is designated Pro-FL. (B) HeLa cells were transiently 
transfected with Notch FL (panels 1–4) or FLK1749R (panels 5–8). Ligand-binding 
assay was performed for 1 h with either control conditioned media (CM) or 
clustered Dl-Fc containing media (Dl-Fc). Notch was detected using an anti-myc 
antibody revealed by an Alexa 488
®–coupled secondary antibody. Even-numbered 
panels show phase-contrast sections (differential interference contrast), odd-num-
bered panels an overlay of differential interference contrast and fluorescence. The 
bottom diagram represents the quantitative analysis of nuclear staining of Dl-Fc–
activated cells (n   28 and 23 for Notch FL and FLK1749R, respectively); 68% of 
WT Notch-expressing cells exhibited at least 40% nuclear staining when activated 
by the ligand, whereas none of the FLK1749R cells did.Monoubiquitination and endocytosis of Notch | Gupta-Rossi et al. 79
docytosis of the transferrin receptor (Fig. 5, A1–A3; punc-
tate red staining). At 4 C (T0), pepex antibody revealed
membrane labeling of all three  E derivatives (Fig. 5,
A1, B1, and C1), thus showing their correct addressing to
the plasma membrane. After 20 min at 37 C, pepex- E
and pepex-LLFF complexes were internalized, whereas the
K1749R mutant remained mainly membrane localized (Fig.
5, A2, B2, and C2). After 45 min, a red perinuclear staining
showed the transferrin receptors in recycling endosomes
(Fig. 5, A3), but none of the Notch derivatives were local-
ized in this compartment (Fig. 5, A3; unpublished data).
Moreover, at this time point, the  E-transfected cells no
longer exhibited pepex staining, although they were positive
for intranuclear Notch staining, as revealed after cell perme-
abilization, by the anti-myc antibody (Fig. 5, A3; in blue).
Thus, it seems that all pepex-bound  E molecules were
 -secretase processed, eliminating the extracellular epitope. On
the other hand, in accordance with the fact that  -secretase
processing could not occur at 45 min, LLFF and K1749R
mutants were still pepex labeled (Fig. 5, B3 and C3), show-
ing colocalization with the anti-myc antibody (Fig. 5, B4
and C4). The K1749R mutant presented less endocytosis
than the LLFF mutant, suggesting that monoubiquitination
may precede late endocytosis. Furthermore, partial colocal-
ization of internalized  E molecules (20-min pepex incuba-
tion; Fig. 5, A4, green) with clathrin light chain (Fig. 5,
CON.1 antibody, red) confirmed that a clathrin-dependent
mechanism was involved. From these results and the bio-
chemical data, we propose that the monoubiquitination step
takes place at the plasma membrane or during early endocy-
tosis, both events being required for the substrate to reach
the compartment where the  -secretase is active.
Discussion
A monoubiquitination event is involved 
in Notch signaling
The ubiquitination pathway involves a multiprotein cascade
in which the substrate specificity is determined by the E3
component (Jackson et al., 2000). Multi-ubiquitin chains at
least four subunits long are required for efficient recognition
and degradation of ubiquitinated proteins by the protea-
some, but ubiquitin has more recently been shown to en-
dorse new functions that do not always involve the protea-
some (Schnell and Hicke, 2003).
Our results show, for the first time, that a monoubiquitin-
ation event takes place on the  E molecule, a constitutively
active form of the Notch receptor that mimics the interme-
diate TACE-processing product generated after ligand bind-
ing. This modification is a prerequisite for  -secretase cleav-
Figure 5. Kinetics of  E endocytosis compared with LLFF and K1749R. HeLa cells were transiently transfected with  E (A panels), LLFF 
(B panels), or K1749R (C panels). Living cells were incubated with an antibody directed against the extracellular part of Notch  E (pepex, in 
green: A1–A4, B1–B3, and C1–C3) and CY3-Tf (in red: A1–A3) at 4 C (T0), or were incubated at 37 C for either 20 min (T20; A2, A4, B2, and 
C2) or 45 min (T45). Cells were fixed, saponin permeabilized, and incubated with anti-myc (in blue: A3, B4, and C4) or anti-clathrin antibodies 
(in red: A4) and the appropriate dye-labeled secondary antibodies. Same fields are presented in B3 and B4, and in C3 and C4. The inset in A4 
shows a higher magnification of the boxed region and highlights  E and clathrin colocalization (in yellow). Preparations were analyzed by 
confocal microscopy (0.3- m sections).80 The Journal of Cell Biology | Volume 166, Number 1, 2004
age and targets one of the subunits of a dimeric membrane-
anchored form of Notch  E. We localized the major site of
monoubiquitination to a juxtamembrane, conserved lysine
residue K1749 in mNotch1. We got access to the monou-
biquitinated form  E
u by coimmunoprecipitation with en-
dogenous PS1 when  -secretase activity was inhibited by a
specific drug. Thus,  E
u is a labile intermediate appearing
before  -secretase cleavage. This form could also be detected
after coexpression of PS1 or  C4, a PS2-derived construct.
These molecules are probably not included into PS-contain-
ing high molecular weight complexes, neither are  -secretase
components when transiently overexpressed (Kimberly et
al., 2003). Thus, they highlight the existence of  E
u by ex-
tracting and stabilizing it out of the active complexes. We
propose that this ubiquitination step is required in the con-
text of the full-length receptor activated by ligand binding.
Although we could not directly access the modified interme-
diate species derived from full-length Notch, mutating the
crucial lysine residue impaired Dll1-mediated Notch signal-
ing, in accordance with the  E results. It remains to be de-
termined which E3 ubiquitin ligase is involved in this modi-
fication. Various proteins carrying such an activity have been
associated with the Notch cascade and are candidates to be
tested (Lai, 2002; Itoh et al., 2003), e.g., Deltex (Diederich
et al., 1994; Fortini and Artavanis-Tsakonas, 1994), Sup-
pressor of Deltex (Qiu et al., 2000), and Cbl (Jehn et al.,
2002). Experiments are in progress to answer this question.
Monoubiquitination and endocytosis trigger 
 -secretase cleavage of activated Notch
Our results show that endocytosis of Notch  E and of
ligand-activated full-length Notch are necessary for  -secre-
tase cleavage. The involvement of a clathrin-dependent en-
docytosis event for Notch activation complies with the mo-
saic analysis performed in Drosophila, which revealed that
shibire function is required in Notch-expressing cells receiv-
ing a lateral inhibition signal (Seugnet et al., 1997). We pro-
pose that monoubiquitination on a juxtamembrane lysine
(K1749) and endocytosis occur after ligand-induced cleav-
age of the Notch extracellular domain by TACE. Our data
are in apparent contradiction with the model proposed by
Lopez-Schier and St. Johnston (2002), according to which
 -secretase cleavage occurs at the plasma membrane. How-
ever, Lopez-Schier’s data can be reinterpreted in light of
our model. These authors argue that the TACE-processing
product of Notch (similar to the  E construct we use) re-
mains associated with the apical membrane in Nicastrin or
PS mutant cells, and in WT cells only a small amount of this
molecule can be found in endocytic vesicles. This result can
be explained by the fact that ubiquitination is one of the
limiting steps in Notch signaling, or that active PS is needed
to direct the final steps of endocytosis of the ubiquitinated
forms. Probably for the same reason,  E is very poorly
cleaved by  -secretase when overexpressed, and the ubiqui-
tination event can hardly be detected. Our results are also in
apparent contradiction with those of Struhl and Adachi
(2000), who postulate that in Drosophila, PS-mediated pro-
teolysis does not appear to require a particular sequence nor
the presence of active dynamin. However, the assay used ap-
pears unusually sensitive, as it even detects the cleavage of
a Notch molecule carrying a G1743V mutation of the
 -secretase cleavage site, a mutation which prevents activa-
tion in most other assays (Huppert et al., 2000) and, when
introduced into mice, gives rise to an almost perfect Notch1
null phenotype. Therefore, a leakage due to overexpression
might in some cases be responsible for the activity detected.
Moreover, these authors use constructs where the intracellu-
lar juxtamembrane domain (containing the conserved lysine
residue) is always present, therefore precluding any conclu-
sion about the importance of this lysine. Finally, species-spe-
cific differences might also be responsible for these discrep-
ancies. Experiments are in progress to test the effect of
mutating the juxtamembrane lysine of Drosophila Notch.
Various papers have described monoubiquitination as a sig-
nal for internalization of receptors such as EGFR or glycine
receptor (Buttner et al., 2001; Haglund et al., 2003; Moses-
son et al., 2003). Our results do not allow one to discriminate
between ubiquitination triggering endocytosis or being con-
comitant with the first steps of endocytosis. However, our ob-
servations show a more internal localization of LLFF com-
pared with the K1749R mutant, and endocytosis of the
K1749R  E mutant seems to be blocked at an earlier stage
when compared with the WT or LLFF mutant. These data
suggest that ubiquitination is necessary for late events driving
Notch to compartments where  -secretase cleavage can occur.
Are ubiquitination and endocytosis general features 
of  -secretase cleavage?
In other regulated intramembrane proteolysis events, trans-
port factors are needed to deliver the substrate to the com-
partment where the enzyme is active (Urban and Freeman,
2002). For example, SCAP is necessary for delivering
SREBP to S2P, and Star for delivering Spitz to rhomboid
(Tsruya et al., 2002; Urban et al., 2002). It is possible, as
suggested by others (Ray et al., 1999), that  E–PS interac-
tion takes place at the plasma membrane. Indeed, the non-
monoubiquitinated  E molecules (mutated on lysine 1749)
are mainly localized at the plasma membrane, but still inter-
act with PS when overexpressed. So PSs could recruit  E-
like activated Notch molecules at the membrane, the com-
plex being then ubiquitinated and internalized to reach the
acidic environment where the  -secretase is active. Alterna-
tively, PS could recruit monoubiquitinated forms of Notch
before endocytosis. It is also of note that a  E
u-like slower
migrating band seems to be stabilized in PS
 /  cells (for ex-
ample see Fig. 5 in Soriano et al., 2001), or in cells treated
with a  -secretase inhibitor (this paper). Furthermore,  E
location varies from plasma membrane to intracytoplasmic
vesicles depending on the mutation affecting PS (Moehl-
mann et al., 2002). These data suggest that ubiquitination
could occur in the absence of active PS, but that Notch–PS
interaction would be required for proper internalization.
Thus, it is tempting to speculate that PSs are bifunctional
proteins, acting first as ubiquitin-dependent chaperones that
target or escort their substrates to the appropriate compart-
ment, and second, as  -secretase enzymes.
Evidence for such a hypothesis does also exist for other
 -secretase substrates. First, APP cleavage was shown to de-Monoubiquitination and endocytosis of Notch | Gupta-Rossi et al. 81
pend on trafficking and membrane fluidity (Fassbender et
al., 2001; Kojro et al., 2001; Wolozin, 2001). At least a
small amount of A  results from cleavage of APP within the
endosomal/lysosomal pathway, particularly in nonneuronal
cells (Haass et al., 1992; Cataldo et al., 2000; Grbovic et al.,
2003). Another relevant observation concerns E-cadherin,
recently described as another substrate for  -secretase. Un-
der conditions of cell–cell dissociation or apoptosis, this TM
molecule is first cleaved in its ectodomain by matrix metallo-
protease, then by a  -secretase activity (Marambaud et al.,
2002). These events promote the disassembly of adherens
junctions in response to apoptotic signals and the subse-
quent release of the intracellular region of E-cadherin in the
cytosol. Hakai, a RING-H2 finger E3 ubiquitin ligase, me-
diates E-cadherin ubiquitination in a tyrosine phosphoryla-
tion–dependent manner, this event leading to E-cadherin
internalization and consequently to the perturbation of cell–
cell adhesions (Fujita et al., 2002). One can combine these
data and imagine that ubiquitination and endocytosis are
also required before  -secretase cleavage in the case of E-cad-
herin, and maybe of other  -secretase substrates.
Remarkably, a lysine residue is present in the juxtamem-
brane region of various  -secretase substrates, such as Notch,
Delta1, Jagged 1 and 2 (Bland et al., 2003; Ikeuchi et al.,
2003; LaVoie and Selkoe, 2003; Six et al., 2003), APP, ErbB-4,
CD44, N and E-cadherins, and a few amino acids COOH-
terminal to their  -secretase cleavage site (Ni et al., 2001;
Lammich et al., 2002; Marambaud et al., 2003). Experiments
are in progress to confirm the validity of this general model.
Materials and methods
Materials
All Notch1 constructs reported here were cloned into the pCS2  vector.
Notch1 constructs,  E,  E CT, ICv, and Notch FL plasmids have been de-
scribed previously (Jarriault et al., 1995; Kopan et al., 1996; Schroeter et
al., 1998); LLFF was a gift from R. Kopan (Washington University, St.
Louis, MO). PS1 and  C4 constructs were supplied by L. Pradier (Aventis,
Vitry, France). HA-tagged ubiquitin was provided by M. Treier (EMBL,
Heidelberg, Germany). Eps15DN, a GFP-tagged, EH-domain–deleted form
of Eps15, the CY3-labeled transferrin, and the anti-clathrin CON.1 anti-
body were provided by A. Dautry-Varsat (Pasteur Institute, Paris, France).
Antibodies were supplied by Cell Signaling (V1744 antibody, recognizing
 -secretase–cleaved Notch1, and P4D1, an mAb against ubiquitin), Mo-
lecular Probes, Inc. (Alexa Fluor
® 488 conjugates), Amersham Biosciences
(CY3-coupled anti–mouse), Biogenesis (anti-Fc), and Jackson ImmunoRe-
search Laboratories (CY5-labeled donkey anti–mouse). Anti-PS1 pAb, di-
rected against either the first 19 amino acids of the molecule (for IP) or the
loop domain (for WB), and anti-PS2 pAb (95041) against the NH2 terminus
of PS2 (Pradier et al., 1999) were gifts from L. Buée (INSERM U422, Lille,
France), C. Haas (Ludwig-Maximillians University, Munich, Germany),
and L. Pradier, respectively. Anti-Notch pAbs have been described previ-
ously (Logeat et al., 1998; Brou et al., 2000). A pAb, named pepex, was
generated against a peptide corresponding to aa 1705–1722 of mNotch1
(Fig. 3 A), coupled to keyhole limpet hemocyanin (Sigma-Aldrich) via an
NH2-terminal cysteine. Anti-HA (12CA5), anti-VSV (P5D4), and anti-myc
(9E10) mAbs were used for immunoprecipitations and isolated on protein
G–sepharose (Amersham Biosciences). N-ethylmaleimide was purchased
from Sigma-Aldrich and Mowiol was purchased from Calbiochem. HEK
293T, HEK 293T stably transfected with a Dl-Fc expression vector (a gift of
G. Weinmaster, Jonsson Cancer Center, Los Angeles, CA; Hicks et al.,
2002), and HeLa cells were cultured in DME supplemented with 10% FBS
and 1% penicillin/streptomycin (GIBCO BRL).
Constructs
The K1749R mutant was generated from  E by site-directed mutagene-
sis using the oligonucleotide 5 -GGGTGCTGCTGTCCCGTCGACGCCG-
GCGGCAGC-3  and its complementary DNA. The FLK1749R mutant was
obtained by inserting a NotI–BglII fragment from  E K1749R into the
Notch FL construct. The  ER5 construct was obtained by inserting an oli-
gonucleotide containing a stop codon at the EcoRV site of  E. Ubiquitins
WTVSV and KOVSV were generated from Ub-WT and UbKO (Wu et al.,
2003) by amplification and insertion into EcoRI–XbaI sites of GVSV-
pcDNA3 (Brou et al., 2000). Each construct was checked by sequencing.
Cell extracts, immunoprecipitations, and immunoblots
293T cells grown on 100-mm dishes were transiently transfected with a to-
tal DNA amount of 10  g equalized with pcDNA3 vector. 40 h after trans-
fection, cells were harvested, washed in PBS buffer, and lysed in 100  l ly-
sis buffer (50 mM Tris-HCl, pH 8.0, 400 mM NaCl, and 1% NP-40)
supplemented with 1  protease inhibitor cocktail (Boehringer), 5 mM
N-ethylmaleimide, and phosphatase inhibitors (Sigma-Aldrich). After 20 min
on ice, cell lysates were cleared at 14,000 rpm for 20 min at 4 C. Immuno-
precipitations were performed with the appropriate antibody after dilution
of the extracts to 50 mM Tris-HCl, 200 mM NaCl, and 0.5% NP-40. Sam-
ples were resuspended in Laemmli buffer for SDS-PAGE resolution on a
6.5% polyacrylamide gel, and immunoblots were performed as described
previously (Brou et al., 2000). 2–20% (when using V1744 antibody) of to-
tal protein lysates were loaded on the same gels for direct immunoblotting.
Immunoblots with anti-ubiquitin antibodies were performed according to
manufacturer’s instructions (Cell Signaling).
Metabolic labeling
Pulse-chase experiments were performed as described previously (Brou et
al., 2000). When mentioned, 50  M MW167 (Partners Neurology) was
added 1 h before the pulse and was maintained during the chase. Extracts
were submitted to anti-myc antibody immunoprecipitation and analyzed
by SDS-PAGE followed by autoradiography.
Endocytosis and ligand-binding assays
HeLa cells were grown on glass coverslips in a 24-well plastic dish, trans-
fected with FuGENE™ 6 as indicated by the supplier (Roche), and treated
24 h after transfection. Endocytosis of transferrin receptor was performed
using the CY3-Tf as described previously (Benmerah et al., 1999), and the
pepex antibody was added (to a 200-fold dilution) when mentioned (Fig. 5
A). Endocytosis was stopped by washing with ice-cold PBS and PFA fixing.
For ligand activation, conditioned media were prepared from control con-
ditioned media or Dl-Fc–expressing (Dl-Fc) 293T cells as described previ-
ously (Hicks et al., 2002). Anti-Fc antibody was added for 1 h at a 200-fold
dilution, then the medium was diluted twice in serum containing DME and
added 1 d after transfection to the cells, for 1 h or overnight at 37 C.
Immunofluorescence and confocal microscopy
Cells were fixed with 4% PFA-PBS for 20 min, quenched for 10 min in 50
mM NH4Cl, permeabilized for 5 min in 0.2% Triton X-100, and incu-
bated for 1 h at RT with the anti-myc antibody. Pepex-incubated cover-
slips were permeabilized with 0.02% saponin. Cells were incubated for
45 min with the appropriate dye-labeled secondary antibodies (anti–
mouse/anti–rabbit Alexa
® 488, anti–mouse CY3, or anti–mouse CY5).
Cell preparations were mounted in Mowiol and images were acquired
using a confocal laser imaging system (LSM 510; Carl Zeiss MicroImag-
ing, Inc.). Quantification was performed using LSM software (LSM SCS
combi, 2.8 sp1; Carl Zeiss MicroImaging, Inc.) on projections of optical
sections to one plane. Both nucleus and total cell were bordered in
phase contrast (differential interference contrast), and the ratio of nuclear
staining was determined as: (nuclear surface   mean nuclear fluores-
cence)/(total cell surface   mean cell fluorescence).
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